AI assistant
Sending…
CYTOKINETICS INC — Director's Dealing 2024
Nov 13, 2024
30870_dirs_2024-11-13_b0a02e66-3cc9-4bd3-b478-e5e27b7fdeb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-11-12
Reporting Person: Malik Fady Ibraham (EVP Research & Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-12 | Common Stock | M | 5300 | $7.96 | Acquired | 120220 | Direct |
| 2024-11-12 | Common Stock | S | 5300 | $58.48 | Disposed | 114920 | Direct |
| 2024-11-12 | Common Stock | S | 1042 | $58.48 | Disposed | 113878 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-12 | Non-Qualified Stock Option (Right to Buy) | $7.96 | M | 5300 | Disposed | 2025-02-26 | Common Stock (5300) | Direct |
More from CYTOKINETICS INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18